InterHealth Nutraceuticals announces the appointment of James Lugo, PhD and Zainulabedin Saiyed, PhD to InterHealth’s R&D department. Dr. Lugo joins InterHealth as the Director of Business Development and Research to spearhead InterHealth’s ambitious product expansion plans. Dr. Saiyed fills another important spot on the R&D team as the R&D manager.
A veteran of the pharmaceutical industry, Dr. Lugo’s extensive background encompasses many phases of marketing, business development and R&D. Dr. Lugo joins InterHealth after a successful career in the pharmaceutical industry where he led new product launches for such companies as Elan Pharmaceuticals and Chugai Pharmaceuticals. He also spent five years at Dey, LP, Napa, California where he re-aligned the neonatal product franchise and grew revenue by over 500% over a five-year period. Dr. Lugo has his PhD in Immunology from MIT and his MBA from UCLA.
As Director of Business and Development and R&D, Dr. Lugo will oversee all related activities including tracking industry trends and developments, identifying and evaluating potential products and managing the new product development process.
Dr. Saiyed came to InterHealth from Florida International University, Miami, Florida, where he was assistant professor in the Department of Immunology, College of Medicine. Dr. Saiyed holds a PhD in Biochemistry from the M.S. University of Baroda, India. While in India, Dr. Saiyed worked at Kemin Industries Ltd as an associate scientist, R&D. Dr. Saiyed is responsible for managing InterHealth’s pipeline of research studies, which will continue to add value to InterHealth’s quality-driven brands and company structure.
In making the announcement, InterHealth CEO Paul Dijkstra stated, “InterHealth has achieved dramatic growth since its establishment in 1987. Dr. Lugo brings vital experience in the pharmaceutical industry that will complement InterHealth’s leadership in the nutraceuticals industry. Dr. Lugo’s leadership will enable the company to reach its ever more ambitious business goals. Dr. Saiyed’s focused expertise in research management will be particularly valuable as we place increasing emphasis on the growth of our brands,” stated Dijkstra. “As we strive to further grow the revenue side of our business, InterHealth remains committed to providing top quality ingredients to its customers.”
“InterHealth is an industry pioneer in co-branding and research-based marketing within the nutraceuticals industry. I look forward to leading the business development and R&D teams as we embark on the company’s next stage of growth,” stated Dr. Lugo.
About InterHealth Nutraceuticals,Inc.
InterHealth Nutraceuticals researches, develops, markets and distributes specialty nutritional ingredients, which are sold worldwide to manufacturers of dietary supplements and nutraceutical food and beverage products. The company’s products include Zychrome™, LOWAT™, Super CitriMax®, UC-II®, ChromeMate®, Aller-7®, OptiBerry®, L-OptiZinc®, Protykin® and ZMA®. For more information about InterHealth and its products, call 1-800-783-4636 or 1-707-751-2800 (outside U.S.) or visit http://www.interhealthusa.com/.